No abstract is provided for this article.
Graphical AbstractHypothetical randomized trial design and steps to develop an individualized decision-making tool in patients with NSTE-ACS and complex coronary artery disease. CABG, coronary artery bypass grafting; DAPT, dual antiplatelet therapy; FFRCT, fractional flow reserve derived from computed tomography; NSTE-ACS, non-ST elevation acute coronary syndrome; PCI, percutaneous coronary intervention.Open in new tabDownload slide
12 year old and 19% of 18 year old Finns.'These differences may be related to the socioeconomic climate in the two countries when the studies were undertaken.The Finnish study was undertaken in Febru- ary 1983, when the percentage of unemployment was 6% (abstracts from the Finnish Embassy's annual statistical year book, 1984 (unpublished)), whereas unemployment in the United Kingdom in March 1984 was 13% and within the city of Nottingham 12%.3War was the second most cited source of anxiety in adolescents from Nottingham (133 (25%) of 538 aged 11-12; 127 (21%) of 626 1 Solantaus T, Rimpela M, Taipale V.The threat of war in the minds of 12-18 year olds in Finland.
1. Cholecystokinin-octapeptide (CCK-OP, 10(-10)-3 x 10(-6) M) produced a concentration-dependent contractile response in guinea-pig trachea which was enhanced by both the mechanical removal of the epithelium and by indomethacin (10(-5) M), with an EC50 of 6.18 +/- 0.10 x 10(-8) M. 2. Sub-threshold concentrations of CCK-OP, which did not alter the resting tone of the smooth muscle, did not alter responses produced to electrical field stimulation (EFS) or to vagal nerve stimulation in an intact tracheal tube preparation. Atropine (2 x 10(-6) M) did not alter the concentration-response curve to CCK-OP, indicating that CCK-OP contraction is not mediated by cholinergic mechanisms. 3. The inhibition of neutral endopeptidase (endopeptidase-24.11) by phosphoramidon (10(-5) M) gave a leftward shift in the CCK-OP concentration-response curve in tissues with intact epithelium obtained from normal animals, but had no effect in tissues denuded of epithelium or in tissues obtained from animals which had been actively sensitized and challenged with ovalbumin (OA). 4. CCK-OP-induced contractile responses were antagonized by the CCK-receptor antagonists dibutyryl cyclic guanosine monophosphate (pA2 = 4.3) and L-364,718 (pA2 = 9.6). 5. CCK-OP induced bronchoconstriction in large, but not small, human airways and was antagonized by the CCK-receptor antagonist L-364,718. CCK-OP had no effect on cholinergic neural responses elicited by EFS in human airways.
Objectives This study was designed to evaluate whether rapid endothelialization of stainless steel stents with a functional endothelium prevents stent thrombosis and reduces the restenotic process. Background A “pro-healing” approach for prevention of post-stenting restenosis is theoretically favored over the use of cytotoxic or cytostatic local pharmacologic therapies. It is believed that the central role of the vascular endothelium is to maintain quiescence of the underlying media and adventitia. Methods Sixteen patients with de novo coronary artery disease were successfully treated with implantation of endothelial progenitor cell (EPC) capture stents. Results Complete procedural and angiographic success was achieved in all 16 patients. The nine-month composite major adverse cardiac and cerebrovascular events (MACCE) rate was 6.3% as a result of a symptom-driven target vessel revascularization in a single patient. There were no other MACCE despite only one month of clopidogrel treatment. At six-month follow-up, mean angiographic late luminal loss was 0.63 ± 0.52 mm, and percent stent volume obstruction by intravascular ultrasound analysis was 27.2 ± 20.9%. Conclusions This first human clinical investigation of this technology demonstrates that the EPC capture coronary stent is safe and feasible for the treatment of de novo coronary artery disease. Further developments in this technology are warranted to evaluate the efficacy of this device for the treatment of coronary artery disease.
Initial geometric imperfections have been identified as the main cause for the large discrepancies between experimental and theoretical buckling loads of thin-walled circular cylindrical shells under axial compression. The extreme sensitivity to imperfections has been previously addressed and mitigated through the introduction of stiffeners; however, sensitivity still remains. Optimized corrugated cylindrical shells are largely insensitive to imperfections and hence exhibit excellent load-bearing capacities, but their complex geometries make their construction difficult and costly using conventional manufacturing techniques. This was overcome in the present study through additive manufacturing (AM). Nine optimized corrugated shells with different diameter-to-thickness ratios, together with one reference circular cylindrical shell, were additively manufactured by means of powder bed fusion (PBF) from austenitic and martensitic precipitation hardening stainless steel. The structural behavior of the AM shells was then investigated experimentally with the testing program comprising tensile coupon tests, measurements of basic geometric properties, and axial compression tests. Numerical analyses were also conducted following completion of the physical experiments. The experimental and numerical results verified the effectiveness of optimized corrugated cylindrical shells in achieving improved local buckling capacity and reduced imperfection sensitivity. Initial recommendations for the structural design of the studied cross-sections are made.